pocketful logo
Aarti Pharmalabs Ltd logo

Aarti Pharmalabs Ltd

NSE: AARTIPHARM BSE: 543748

₹681.20

(-0.80%)

Mon, 16 Mar 2026, 04:29 am

Aarti Pharmalabs Enterprise Value (EV)

Particulars20202021202220232024
Price to earnings ratio0012.8618.1824.92
Price to book ratio001.602.243.41
Price to sales ratio001.282.173.25
Price to cash flow ratio0010.8219.5021.61
Enterprise value0026.41B41.33B71.46B
Enterprise value to EBITDA ratio007.8611.6516.17
Debt to equity ratio00.250.140.160.21
Return on equity %017.6313.1413.0814.54

Aarti Pharmalabs Ltd Enterprise Value

The Aarti Pharmalabs Ltd Enterprise Value is a key financial metric used by investors to evaluate Aarti Pharmalabs Ltd's valuation, profitability, and overall financial performance. Tracking the Aarti Pharmalabs Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Aarti Pharmalabs Ltd (NSE: AARTIPHARM, BSE: 543748) is currently trading at ₹681.20, with a market capitalization of ₹62.15B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Aarti Pharmalabs Ltd Enterprise Value is essential for fundamental analysis.

Aarti Pharmalabs Ltd Enterprise Value Current Value

The current Aarti Pharmalabs Ltd Enterprise Value stands at 71.46B.

The latest Aarti Pharmalabs Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Aarti Pharmalabs Ltd Enterprise Value Historical Trend

The Aarti Pharmalabs Ltd Enterprise Value has shown the following historical trend:

  • 2024: 71.46B
  • 2023: 41.33B
  • 2022: 26.41B
  • 2021: 0
  • 2020: 0

The recent rise in Aarti Pharmalabs Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.

What Aarti Pharmalabs Ltd Enterprise Value Indicates for Investors

The Aarti Pharmalabs Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Aarti Pharmalabs Ltd.

Aarti Pharmalabs Ltd Enterprise Value Analysis Summary

The Aarti Pharmalabs Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Aarti Pharmalabs Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Aarti Pharmalabs Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800